Zota Health Care Board Approves 26th AGM, Appoints New Director, Declares Dividend
Zota Health Care Limited's Board approved the 26th AGM on September 28, 2026. Record date for dividend and e-voting is September 21, 2026. Mr. Mahaveer Dhariwal appointed as Additional Independent Director. Dividend of Re. 1 per equity share (10%) for FY 2025-26 approved.
The appointment of a new independent director and the declaration of a dividend are significant corporate actions that can influence investor confidence and company governance. The scheduling of the AGM and related party transactions also have a medium-term impact on stakeholders.
The announcement details routine corporate governance matters such as board meetings, AGM scheduling, dividend declaration, and director appointments. While these are important for stakeholders, they do not indicate a significant positive or negative shift in the company's operational or financial performance.
Zota Health Care Limited's Board of Directors convened on September 3, 2026, approving key decisions including the Director's Report for the fiscal year ended March 31, 2026. The Board has scheduled the 26th Annual General Meeting (AGM) for Monday, September 28, 2026, at 11:00 AM, to be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM).
For the purpose of the final dividend payment and e-voting, Monday, September 21, 2026, has been set as the record date. The dividend will be paid to eligible equity shareholders whose names are registered on the company's register of members by the close of business hours on September 21, 2026. The e-voting facility will be available from Friday, September 25, 2026, at 9:00 AM, until Sunday, September 27, 2026, at 5:00 PM. Mr. Ranjit Binod Kejriwal has been appointed as the Scrutinizer for the remote e-voting process and votes cast during the AGM.
Furthermore, the Board has approved the appointment of Mr. Mahaveer Dhariwal as an Additional Director, designated as an Independent Director. He will hold this position for five consecutive years, commencing from September 3, 2026, subject to shareholder approval at the AGM. The AGM agenda also includes the re-appointment of Mr. Moxesh Ketanbhai Zota as Managing Director for a further five-year term and the approval of remuneration for Mr. Ketankumar Chandulal Zota, the Non-Executive Chairman. The meeting will also seek approval for related party transactions, including a loan of up to ₹40.00 crore to its subsidiary, Everyday Herbal Beauty Care Limited, and sale/purchase of goods/products/materials up to ₹100.00 crore for FY 2026-27. Additionally, approval is sought for supply chain management services and brand usage/royalty payments to the subsidiary.
A plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.